NCT00421915View on ClinicalTrials.gov

Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis

PHASE3CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

March 31, 2002

Study Completion Date

August 31, 2002

Conditions
Ankylosing Spondylitis
Interventions
DRUG

Enbrel (etanercept)

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00421915 - Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis | Biotech Hunter | Biotech Hunter